Literature DB >> 19333726

Insulin resistance acts as an independent risk factor exacerbating high-purine diet induced renal injury and knee joint gouty lesions.

Zhimin Miao1, Shengli Yan, Jing Wang, Bei Wang, Yujun Li, Xiaoming Xing, Ying Yuan, Dongmei Meng, Luan Wang, Jianguo Gu, Shu Zhang, Changgui Li, Cong-Yi Wang.   

Abstract

OBJECTIVE AND
DESIGN: Insulin resistant Otsuka-Long-Evans-Tokushima Fatty (OLETF) and its control Long-Evans Tokushima Ohtsuka (LETO) rats were used to generate a model for acute hyperuricemia. Upon the onset of insulin resistance OLETF rats were feed with high-purine diet, and the development of acute hyperuricemic renal injury and gouty-like lesions was monitored. Rosiglitazone was also administered to demonstrate whether improved insulin sensitivity would prevent high-purine diet induced renal injury and gouty-like lesions.
RESULTS: Otsuka-Long-Evans-Tokushima Fatty rats showed significant higher incidence of hyperuricemia as compared to the control LETO rats (77 vs. 36.1%, P < 0.05), indicating that insulin resistance exacerbates the development of hyperuricemia following high-purine load. Consistent with this observation, improvement of insulin sensitivity by administration of rosiglitazone significantly reduced high-purine diet induced renal injury and gouty-like lesions. It was found that insulin resistance is associated with impaired capability for maintaining the homeostasis of renal uric acid excretion and reabsorption. Upon high-purine load, insulin resistance enhances urate reabsorption as manifested by up-regulated URAT1 expression and reduces urate excretion as characterized by down-regulated UAT expression.
CONCLUSIONS: Our data demonstrated strong evidence indicating that insulin resistance acts as an independent risk factor predisposing OLETF rats more susceptible to the development of hyperuricemia and gouty arthritis following high-purine load.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19333726     DOI: 10.1007/s00011-009-0031-9

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  32 in total

Review 1.  Gout: excess calories, purines, and alcohol intake and beyond. Response to a urate-lowering diet.

Authors:  Adel G Fam
Journal:  J Rheumatol       Date:  2005-05       Impact factor: 4.666

2.  On Filipino hyperuricemia.

Authors:  P S Bayani-Sioson; M Skeith; L S Healey
Journal:  Acta Med Philipp       Date:  1966 Oct-Dec

3.  Lack of satiety effect of cholecystokinin (CCK) in a new rat model not expressing the CCK-A receptor gene.

Authors:  K Miyasaka; S Kanai; M Ohta; T Kawanami; A Kono; A Funakoshi
Journal:  Neurosci Lett       Date:  1994-10-24       Impact factor: 3.046

4.  Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database.

Authors:  Enzo Bonora; Brunella Capaldo; Paolo Cavallo Perin; Stefano Del Prato; Giancarlo De Mattia; Lucia Frittitta; Simona Frontoni; Frida Leonetti; Livio Luzi; Giulio Marchesini; Maria Adelaide Marini; Andrea Natali; Giuseppe Paolisso; Pier Marco Piatti; Arturo Pujia; Anna Solini; Roberto Vettor; Riccardo C Bonadonna
Journal:  Nutr Metab Cardiovasc Dis       Date:  2007-12-03       Impact factor: 4.222

5.  Prevalence of the metabolic syndrome in individuals with hyperuricemia.

Authors:  Hyon K Choi; Earl S Ford
Journal:  Am J Med       Date:  2007-05       Impact factor: 4.965

6.  Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK.

Authors:  T H Moran; P J Ameglio; G J Schwartz; P R McHugh
Journal:  Am J Physiol       Date:  1992-01

7.  Purine-rich foods, dairy and protein intake, and the risk of gout in men.

Authors:  Hyon K Choi; Karen Atkinson; Elizabeth W Karlson; Walter Willett; Gary Curhan
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

8.  Effects of obesity and inheritance on the development of non-insulin-dependent diabetes mellitus in Otsuka-Long-Evans-Tokushima fatty rats.

Authors:  N Okauchi; A Mizuno; M Zhu; K Ishida; T Sano; Y Noma; K Shima
Journal:  Diabetes Res Clin Pract       Date:  1995-07       Impact factor: 5.602

9.  Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China.

Authors:  Zhimin Miao; Changgui Li; Ying Chen; Shihua Zhao; Yangang Wang; Zhongchao Wang; Xinyan Chen; Feng Xu; Fang Wang; Ruixia Sun; Jianxia Hu; Wei Song; Shengli Yan; Cong-Yi Wang
Journal:  J Rheumatol       Date:  2008-07-15       Impact factor: 4.666

10.  Uric acid: a surrogate of insulin resistance in older women.

Authors:  Liang-Kung Chen; Ming-Hsien Lin; Hsiu-Yun Lai; Shinn-Jang Hwang; Shu-Ti Chiou
Journal:  Maturitas       Date:  2007-12-21       Impact factor: 4.342

View more
  12 in total

1.  Hyperuricemia: a reality in the Indian obese.

Authors:  Carlyne Remedios; Miloni Shah; Aparna Govil Bhasker; Muffazal Lakdawala
Journal:  Obes Surg       Date:  2012-06       Impact factor: 4.129

2.  Associations of Triglyceride-Glucose Index and Its Derivatives with Hyperuricemia Risk: A Cohort Study in Chinese General Population.

Authors:  Qing Gu; Xue Hu; Jian Meng; Jun Ge; Sui Jun Wang; Xing Zhen Liu
Journal:  Int J Endocrinol       Date:  2020-09-17       Impact factor: 3.257

3.  Renal clearance of uric acid is linked to insulin resistance and lower excretion of sodium in gout patients.

Authors:  Fernando Perez-Ruiz; Maria Angeles Aniel-Quiroga; Ana María Herrero-Beites; Sandra Pamela Chinchilla; Gorka Garcia Erauskin; Toni Merriman
Journal:  Rheumatol Int       Date:  2015-03-13       Impact factor: 2.631

4.  TJ0711, a novel vasodilatory β-blocker, protects SHR rats against hypertension induced renal injury.

Authors:  Juan Yang; Yong Ning; Jun Qiu; Jin-Seng He; Wei Li; Zu-Fu Ma; Ju-Fang Shao; Yue-Qiang Li; Rui Zeng; Meng Zhang; Jia Cheng; Su-Fang Chen; Gang Xu; Cong-Yi Wang; Ying Yao
Journal:  Am J Transl Res       Date:  2013-04-19       Impact factor: 4.060

5.  Impacts of Anthropometric, Biochemical, Socio-demographic, and Dietary Habits Factors on the Health Status of Urban Corporate People in a Developing Country.

Authors:  Masuda Begum Sampa; Md Rakibul Hoque; Md Nazmul Hossain
Journal:  Healthcare (Basel)       Date:  2020-06-27

6.  27-Hydroxycholesterol regulates human SLC22A12 gene expression through estrogen receptor action.

Authors:  Masaya Matsubayashi; Yoshihiko M Sakaguchi; Yoshiki Sahara; Hitoki Nanaura; Sotaro Kikuchi; Arvand Asghari; Linh Bui; Shinko Kobashigawa; Mari Nakanishi; Riko Nagata; Takeshi K Matsui; Genro Kashino; Masatoshi Hasegawa; Shin Takasawa; Masahiro Eriguchi; Kazuhiko Tsuruya; Shushi Nagamori; Kazuma Sugie; Takahiko Nakagawa; Minoru Takasato; Michihisa Umetani; Eiichiro Mori
Journal:  FASEB J       Date:  2021-01       Impact factor: 5.191

7.  Effects of a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator, Pemafibrate, on Metabolic Parameters: A Retrospective Longitudinal Study.

Authors:  Hidekatsu Yanai; Hisayuki Katsuyama; Mariko Hakoshima
Journal:  Biomedicines       Date:  2022-02-08

8.  Comparing the effects of inorganic nitrate and allopurinol in renovascular complications of metabolic syndrome in rats: role of nitric oxide and uric acid.

Authors:  Soha S Essawy; Khaled A Abdel-Sater; Amani A Elbaz
Journal:  Arch Med Sci       Date:  2013-03-06       Impact factor: 3.318

9.  Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: A study on Bangladeshi adults.

Authors:  Nurshad Ali; Rasheda Perveen; Shahnaz Rahman; Shakil Mahmood; Sadaqur Rahman; Shiful Islam; Tangigul Haque; Abu Hasan Sumon; Rahanuma Raihanu Kathak; Noyan Hossain Molla; Farjana Islam; Nayan Chandra Mohanto; Shaikh Mirja Nurunnabi; Shamim Ahmed; Mustafizur Rahman
Journal:  PLoS One       Date:  2018-11-01       Impact factor: 3.240

10.  An Intron Variant of SLC2A9 Increases the Risk for Type 2 Diabetes Mellitus Complicated with Hyperuricemia in Chinese Male Population.

Authors:  Xuan-Long Yi; Jiang Li; Dong-Mei Meng; Yan-Jun Liu; Yan-Hong Liu; Hong-Min Ma; Ying Yuan; Shi-Chao Xing
Journal:  Iran J Public Health       Date:  2018-06       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.